Biblio

Export 3292 results:
Author Title [ Type(Desc)] Year
Journal Article
H. - J. Kim, Im, H. Kyun, Kim, J., Han, J. - Y., de Leon, M., Deshpande, A., and Moon, W. - J., “Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1101-9, 2016.
Y. Kuttner-Hirshler, Venkatasubramanian, P. N., Apolinario, J., Bonds, J., Wyrwicz, A. M., and Lazarov, O., “Brain Biomarkers in Familial Alzheimer's Disease Mouse Models.”, J Alzheimers Dis, vol. 60, no. 3, pp. 949-958, 2017.
C. M Selles, Oliveira, M. M., and Ferreira, S. T., “Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S313-S327, 2018.
P. Caffarra, Ghetti, C., Ruffini, L., Spallazzi, M., Spotti, A., Barocco, F., Guzzo, C., Marchi, M., and Gardini, S., “Brain Metabolism Correlates of the Free and Cued Selective Reminding Test in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 51, no. 1, pp. 27-31, 2016.
E. D. Huey, Lee, S., Cheran, G., Grafman, J., and Devanand, D. P., “Brain Regions Involved in Arousal and Reward Processing are Associated with Apathy in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 55, no. 2, pp. 551-558, 2017.
Y. Vermeiren, Janssens, J., Aerts, T., Martin, J. - J., Sieben, A., Van Dam, D., and De Deyn, P. P., “Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1079-96, 2016.
Y. Huang, Driedonks, T. A. P., Cheng, L., Rajapaksha, H., Routenberg, D. A., Nagaraj, R., Redding, J., Arab, T., Powell, B. H., Pletniková, O., Troncoso, J. C., Zheng, L., Hill, A. F., Mahairaki, V., and Witwer, K. W., “Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease Display Altered Key Protein Levels Including Cell Type-Specific Markers.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1057-1072, 2022.
N. Boublay, Bouet, R., Dorey, J. - M., Padovan, C., Makaroff, Z., Federico, D., Gallice, I., Barrellon, M. - O., Robert, P., Moreaud, O., Rouch, I., and Krolak-Salmon, P., “Brain Volume Predicts Behavioral and Psychological Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1343-1353, 2020.
K. Ndukwe, Serrano, P. A., Rockwell, P., Xie, L., and Figueiredo-Pereira, M. E., “Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer's disease rat model.”, J Alzheimers Dis, p. 13872877251314777, 2025.
P. T. Francis, Costello, H., and Hayes, G. M., “Brains for Dementia Research: Evolution in a Longitudinal Brain Donation Cohort to Maximize Current and Future Value.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1635-1644, 2018.
S. Pandya, Kuceyeski, A., and Raj, A., “The Brain's Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1639-1657, 2017.
F. Guillot, Kemppainen, S., Lavasseur, G., Miettinen, P. O., Laroche, S., Tanila, H., and Davis, S., “Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1157-73, 2016.
A. Zhu, Wu, Z., Zhong, X., Ni, J., Li, Y., Meng, J., Du, C., Zhao, X., Nakanishi, H., and Wu, S., “Brazilian Green Propolis Prevents Cognitive Decline into Mild Cognitive Impairment in Elderly People Living at High Altitude.”, J Alzheimers Dis, vol. 63, no. 2, pp. 551-560, 2018.
E. L. Goldwaser, Acharya, N. K., Sarkar, A., Godsey, G., and Nagele, R. G., “Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 445-56, 2016.
H. - F. Wang, Wan, Y., Hao, X. - K., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Tan, L., Zhang, D. - Q., Tan, L., and Yu, J. - T., “Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.”, J Alzheimers Dis, vol. 52, no. 1, pp. 179-90, 2016.
R. E. Curiel, Crocco, E., Rosado, M., Duara, R., Greig, M. T., Raffo, A., and Loewenstein, D. A., “A Brief Computerized Paired Associate Test for the Detection of Mild Cognitive Impairment in Community-Dwelling Older Adults.”, J Alzheimers Dis, vol. 54, no. 2, pp. 793-9, 2016.
W. B. Grant, “A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. s1, pp. S165-S178, 2024.
H. Li, Luo, X. - B., Xu, Y., and Hou, X. - Y., “A Brief Ischemic Postconditioning Protects Against Amyloid-β Peptide Neurotoxicity by Downregulating MLK3-MKK3/6-P38MAPK Signal in Rat Hippocampus.”, J Alzheimers Dis, vol. 71, no. 2, pp. 671-684, 2019.
S. Gourmaud, Thomas, P., Thomasseau, S., Tible, M., Abadie, C., Paquet, C., and Hugon, J., “Brimapitide Reduced Neuronal Stress Markers and Cognitive Deficits in 5XFAD Transgenic Mice.”, J Alzheimers Dis, vol. 63, no. 2, pp. 665-674, 2018.
I. A. Clark and Vissel, B., “Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.”, J Alzheimers Dis, vol. 79, no. 3, pp. 931-948, 2021.
T. J. Nelson, Sun, M. - K., Lim, C., Sen, A., Khan, T., Chirila, F. V., and Alkon, D. L., “Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer's Disease Phase IIa and Expanded Access Trials.”, J Alzheimers Dis, vol. 58, no. 2, pp. 521-535, 2017.
W. R. Leifert, Nguyen, T., Rembach, A., Martins, R., Rainey-Smith, S., Masters, C. L., Ames, D., Rowe, C. C., S Macaulay, L., François, M., and Fenech, M. F., “Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 48, no. 2, pp. 443-52, 2015.
R. Benca, W Herring, J., Khandker, R., and Qureshi, Z. P., “Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.”, J Alzheimers Dis, vol. 86, no. 1, pp. 83-109, 2022.
L. De Beaumont, Pelleieux, S., Lamarre-Théroux, L., Dea, D., and Poirier, J., “Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.”, J Alzheimers Dis, vol. 54, no. 3, pp. 913-922, 2016.
A. R. Haeusler, Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M. - S., Maragakis, N. J., Troncoso, J. C., Pandey, A., Sattler, R., Rothstein, J. D., and Wang, J., “C9orf72 nucleotide repeat structures initiate molecular cascades of disease.”, Nature, vol. 507, no. 7491, pp. 195-200, 2014.

Pages